FT. COLLINS, CO-Cytomation Inc., an international biotechinstrumentation company, is doubling the size of its headquartersin this northern Colorado city.

Cytomation, maker of the what are said to be the world's fastestsingle-cell analyzers and sorters, is building a $3-million,24,000-sf facility in southeast Ft. Collins, about a 90-minutedrive north of Denver. Ft. Collins is home to Colorado StateUniversity.

The company already has an adjacent 11,000-sf manufacturingfacility. In addition, the company will lease 15,000-sf of newbuildings, the first of three phases for a $7-million, 80,000-sfcampus positioned on eight acres. “Cytomation has seen tremendousgrowth in recent years, and we don't expect it to slow down anytimesoon,” says Nigel Ferrey, company president and CEO.The company'sflagship instrument, on the market since 1994, was initiallydeveloped to sort chromosomes for the Human Genome Project. Itsproducts are now used for everything from cancer and HIV researchto livestock sex selection.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.